Publications with Prof. Kim
9. Choi, M.Y.*, Jo, M.G.*, Min, K.Y., Kim, B., Kim, Y., Choi, W.S.* Antimicrobial Peptide Pro10-1D Exhibits Anti-Allergic Activity: A Promising Therapeutic Candidate. International Journal of Molecular Sciences. 2024 Nov 12;25(22):12138. doi: 10.3390/ijms252212138.
8. Lee, D.*, Jo, M.G.*, Min, K.Y., Choi, M.Y., Kim, Y.M., Kim, H.S.*, Choi, W.S.* IL-10+ regulatory B cells mitigate atopic dermatitis by suppressing eosinophil activation. Scientific Reports. 2024 Aug 6; 14(1):18164. doi:10.1038/s41598-024-68660-9.
7. Min, K.Y.*, Kim, D.K.*, Jo, M.G., Choi, M.Y., Lee, D., Park, J.W., Park, Y.J., Chung, Y., Kim, Y.M., Park, Y.M., Kim, H.S.*, Choi, W.S.* IL-27-induced PD-L1highSca-1+ innate lymphoid cells suppress contact hypersensitivity in an IL-10-dependent manner. Experimental & Molecular Medicine. 2024 Mar 1; 56(3):616-629. doi: 10.1038/s12276-024-01187-1. (IF 12.8 JCR 2022)
6. Lee, J.E., Choi, M.Y., Min, K.Y., Jo, M.G., Kim, Y.M., Kim, H.S., Choi, W.S. Drug repositioning of anti-microbial agent nifuratel to treat mast cell-mediated allergic responses. International Journal of Immunopathology and Pharmacology. 2023 Jan-Dec;37:3946320231202349. doi: 10.1177/03946320231202349.
5. Kim, S.J.*, Choi, M.Y.*, Min, K.Y., Jo, M.G., Kim, J.M., Kim, H.S., Kim, Y.M. AT9283, 1-Cyclopropyl-3-(3-(5-(Morpholinomethyl)-1H-Benzo[d]Imidazole-2-yl)-1H-Pyrazol-4-yl) Urea, Inhibits Syk to Suppress Mast Cell-Mediated Allergic Response. Biomolecules & Therapeutics. 2022 Nov 1; 30(6):520-528. doi: 10.4062/biomolther.2022.042.
4. Min, K.Y.*, Koo, J.*, Noh, G., Lee, G., Jo, M.G., Lee, J., Kang, M., Hyun, S.Y., Choi,W.S.*, Kim, H.S.* CD1dhiPD-L1hiCD27+ regulatory natural killer subset suppresses atopic dermatitis. Frontiers in Immunology. 2022 Jan 5;12: 752888. (IF 8.786 JCR 2021)
3. Min, K.Y., Lee, M.B., Hong, S.H., Lee, D., Jo, M.G., Lee, J., Choi, M.Y., You, J.S., Kim, Y.M., Park, Y.M., Kim, H.S.*, Choi, W.S.* Entinostat, a histone deacetylase inhibitor, increases the population of IL-10+ regulatory B cells to suppress contact hypersensitivity. BMB Reports. 2021 Oct 31;54(10): 534-539. (IF 5.041 JCR 2021)
2. Lee, D., Park, Y.H., Lee, J.E., Kim, H.S., Min, K.Y., Jo, M.G., Kim, H.S., Choi, W.S., Kim, Y.M. Dasatinib Inhibits Lyn and Fyn Src-Family Kinases in Mast Cells to Suppress Type I Hypersensitivity in Mice. Biomolecules & Therapeutics. 2020 Sep 1;28(5):456-464.
1. Park, Y.H.*, Kim, D.K.*, Kim, H.S.*, Lee, D., Lee, M.B., Min, K.Y., Jo, M.G., Lee, J.E., Kim, Y.M., Choi, W.S. WZ3146 inhibits mast cell Lyn and Fyn to reduce IgE-mediated allergic responses in vitro and in vivo. Toxicology and Applied Pharmacology. 2019 Nov 15;383: 114763.
Publications with Prof. Kim
4. Park, J.W.*, Kang, M.*, Kim, G.*, Hyun, S.Y., Shin, J., Kim, S.Y., Lee, J.H., Choi, W.S., Lee, J.H., Lee, K., Kim, S.H., Cho, W.S.*, Kim, H.S.* The impact of atmospheric ultrafine particulate matter on IgE-mediated type 1 hypersensitivity reaction. Journal of Hazardous Materials. 2025 Feb 15;484:136705. doi: 10.1016/j.jhazmat. 2024.136705. (IF 12.2 JCR 2023) Epub 2024 Nov 29.
3. Shin, J.H., Park, J.W., Kim, S.Y., Lee, J.H., Choi, W.S., Kim, H.S. Strategies for Overcoming Immune Evasion in Bladder Cancer. International Journal of Molecular Sciences. 2024 Mar 7;25(6):3105. doi: 10.3390/ijms25063105.
2. Min, K.Y.*, Kim, D.K.*, Jo, M.G., Choi, M.Y., Lee, D., Park, J.W., Park, Y.J., Chung, Y., Kim, Y.M., Park, Y.M., Kim, H.S.*, Choi, W.S.* IL-27-induced PD-L1highSca-1+ innate lymphoid cells suppress contact hypersensitivity in an IL-10-dependent manner. Experimental & Molecular Medicine. 2024 Mar 1; 56(3):616-629. doi: 10.1038/s12276-024-01187-1. (IF 12.8 JCR 2022)
1. Hyun, S.Y.*, Kim, E.Y.*, Kang, M.S., Park, J.W., Hong, K.S., Chung, H.M., Choi, W.S., Park, S.P.*, Noh, G.*, Kim, H.S.* Embryonic‑stem‑cell‑derived mesenchymal stem cells relieve experimental contact urticaria by regulating the functions of mast cells and T cells. Scientific Reports. 2023 Dec 20; 13:22694. doi: 10.1038/s41598-023-50258-2.
Publications with Prof. Kim
2. Park, J.W.*, Kang, M.*, Kim, G.*, Hyun, S.Y., Shin, J., Kim, S.Y., Lee, J.H., Choi, W.S., Lee, J.H., Lee, K., Kim, S.H., Cho, W.S.*, Kim, H.S.* The impact of atmospheric ultrafine particulate matter on IgE-mediated type 1 hypersensitivity reaction. Journal of Hazardous Materials. 2025 Feb 15;484:136705. doi: 10.1016/j.jhazmat. 2024.136705. (IF 12.2 JCR 2023) Epub 2024 Nov 29.
1. Shin, J., Park, J.W., Kim, S.Y., Lee, J.H., Choi, W.S., Kim, H.S. Strategies for Overcoming Immune Evasion in Bladder Cancer. International Journal of Molecular Sciences. 2024 Mar 7;25(6):3105. doi: 10.3390/ijms25063105.
Publications with Prof. Kim
2. Park, J.W.*, Kang, M.*, Kim, G.*, Hyun, S.Y., Shin, J., Kim, S.Y., Lee, J.H., Choi, W.S., Lee, J.H., Lee, K., Kim, S.H., Cho, W.S.*, Kim, H.S.* The impact of atmospheric ultrafine particulate matter on IgE-mediated type 1 hypersensitivity reaction. Journal of Hazardous Materials. 2025 Feb 15;484:136705. doi: 10.1016/j.jhazmat. 2024.136705. (IF 12.2 JCR 2023) Epub 2024 Nov 29.
1. Shin, J., Park, J.W., Kim, S.Y., Lee, J.H., Choi, W.S., Kim, H.S. Strategies for Overcoming Immune Evasion in Bladder Cancer. International Journal of Molecular Sciences. 2024 Mar 7;25(6):3105. doi: 10.3390/ijms25063105.